Gilead Sciences, Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Gilead Sciences with three other
pharmaceutical manufacturers in North America:
sales of $36.48 billion
of which 59%
Merck & Co. , Inc.
of which 88%
was Merck Pharmaceutical), and
of which 85%
Gilead Sciences reported sales of $32.64 billion
December of 2015.
increase of 31.1%
versus 2014, when the company's sales were $24.89 billion.
Sales at Gilead Sciences have increased during each of the previous five years
(and since 2010, sales have increased a total of 311%).